Investing
Comprehensive investing news, insights and opinions from the MoneyWeek team and the top voices in the investment sector. Covering market moves, the latest stock prices and the best funds and trusts to buy.
Explore Investing
-
RentGuarantor Holdings: a small upstart with huge potentialNewly-listed RentGuarantor Holdings should benefit from the Renters' Rights Act, even though it's a headache for landlords. Should you invest?
By Rupert Hargreaves Published
-
Archer Aviation, an overvalued flying-car firmFlying-car company Archer Aviation's plans have yet to get off the ground, and the group is bleeding cash. What should investors do?
By Dr Matthew Partridge Published
-
Three funds to help investors thriveThree very different funds for investors looking to diversify their portfolios, as picked by James Yardley, manager of the VT Chelsea Managed Funds range
By James Yardley Published
-
Edinburgh Worldwide must show some independenceOpinion Edinburgh Worldwide Investment Trust's new board should reject an ill-conceived proposal from activist investor Saba Capital, says Max King
By Max King Published
Opinion -
8 of the best properties for sale with summer housesThe best properties for sale with summer houses – from a duplex flat in a period property in Edinburgh to a Grade II-listed Cornish long house in Penzance.
By Natasha Langan Published
-
ESG investing is maturing – here's how to buy inThe market for ESG investing is maturing despite the political headwinds, and remains a key tenet of the global investment landscape
By Maryam Cockar Published
-
Emerging markets rally despite the energy crisisThe surprisingly strong performance of the MSCI Emerging Markets index is down to a few beneficiaries of the AI boom – but can it last?
By Cris Sholto Heaton Published
-
Are UK stocks undervalued?UK stocks are some of the cheapest in the world at the moment. Is this an opportunity to back British?
By Dan McEvoy Last updated
-
Biotech’s recovery is underway. And investors are about to miss itSponsor Content Created With RTW Investments
Deal activity is accelerating, a new generation of cancer treatments is reaching patients and biotech is becoming profitable. The case for the sector in 2026 is stronger than it was a year ago.
By MoneyWeek Published




